Naoshi Obara - Division of HematologyInstitute of Clinical Medicine, University of Tsukuba

Zenjiro Sampei, Kenta Haraya, Siok Wan Gan,Masaru Muraoka,Akira Hayasaka, Taku Fukuzawa, Meiri Shida-Kawazoe, Yoshinori Tsuboi,Akihiko Gotoh,Naoshi Obara, Yasutaka Ueda

International Journal of Molecular Sciencesno. 21 (2024): 11679

Cited0Views0Bibtex

Long-term Safety and Effectiveness of Romiplostim for Chronic Idiopathic Thrombocytopenic Purpura in Real-World Settings

Naoshi Obara, Shigeki Hatanaka,Yukie Tsuji, Koji Higashi

International Journal of Hematologypp.1-10, (2024)

Cited0Views0WOSBibtex

[Durable remission of T-cell prolymphocytic leukemia with CLEC16A::IL2 after allogeneic hematopoietic stem cell transplantation]

Haruka Momose,Naoki Kurita,Hidekazu Nishikii,Nozomi Yusa,Kazuaki Yokoyama,Eigo Shimizu,Seiya Imoto,Toru Nanmoku,Yumiko Maruyama,Tatsuhiro Sakamoto,Yasuhisa Yokoyama,Takayasu Kato,Ryota Matsuoka,Naoshi Obara,Mamiko Sakata-Yanagimoto,Shigeru Chiba

[Rinsho ketsueki] The Japanese journal of clinical hematologyno. 1 (2024): 35-40

Cited0Views0WOSBibtex

Impact of CD34 Positive Cell Dose in Donor Graft on the Outcomes after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide – A Retrospective Single-Center Study with a Japanese Cohort

Yumiko Maruyama,Hidekazu Nishikii,Naoki Kurita,Tatsuhiro Sakamoto,Keiichiro Hattori,Yasuhito Suehara,Yasuhisa Yokoyama,Takayasu Kato,Naoshi Obara,Mamiko Sakata-Yanagimoto,Shigeru Chiba

BLOOD CELLS MOLECULES AND DISEASES (2024)

Cited0Views0WOSBibtex

A Phase 2, Open-Label Study of Ibrutinib Plus Rituximab in Japanese Patients with Waldenstrom’s Macroglobulinemia

Koji Izutsu,Hisashi Kato,Naohiro Sekiguchi,Tomoaki Fujisaki,Toshiro Kawakita,Naoshi Obara,Kosei Matsue,Mitsutaka Nishimoto,Tomoyoshi Hatayama,Mitsuo Inagaki,Ei Fujikawa

International Journal of Hematology（2024）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn